Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexei V. Deykin"'
Autor:
Tatiana V. Egorova, Evgenia D. Zotova, Denis A. Reshetov, Anna V. Polikarpova, Svetlana G. Vassilieva, Dmitry V. Vlodavets, Alexey A. Gavrilov, Sergey V. Ulianov, Vladimir L. Buchman, Alexei V. Deykin
Publikováno v:
Disease Models & Mechanisms, Vol 12, Iss 4 (2019)
Exon skipping is a promising strategy for Duchenne muscular dystrophy (DMD) disease-modifying therapy. To make this approach safe, ensuring that excluding one or more exons will restore the reading frame and that the resulting protein will retain cri
Externí odkaz:
https://doaj.org/article/316b1ecf089f4dba993bcc8630736791
Autor:
Sergey O. Bachurin, Kirill D. Chaprov, T. A. Ivanova, Michail S. Kukharsky, Alexander P. Rezvykh, Vladimir L. Buchman, Ekaterina A. Lysikova, Sergei Funikov, Alexei V. Deykin, Natalia Ninkina, Alexey Yu. Aksinenko
Publikováno v:
CNS Neuroscience & Therapeutics
Aims To assess effects of DF402, a bioisostere of Dimebon/Latrepirdine, on the disease progression in the transgenic model of amyotrophic lateral sclerosis (ALS) caused by expression of pathogenic truncated form of human FUS protein. Methods Mice rec
Autor:
Svetlana G. Vassilieva, Dmitry V. Vlodavets, A. V. Polikarpova, Alexey A. Gavrilov, Denis A. Reshetov, Sergey V. Ulianov, Vladimir L. Buchman, Evgenia D. Zotova, Alexei V. Deykin, Tatiana V. Egorova
Publikováno v:
Disease Models & Mechanisms, Vol 12, Iss 4 (2019)
Disease Models & Mechanisms
Disease Models & Mechanisms
Exon skipping is a promising strategy for Duchenne muscular dystrophy (DMD) disease-modifying therapy. To make this approach safe, ensuring that excluding one or more exons will restore the reading frame and that the resulting protein will retain cri